Alzheimer disease and cerebrovascular pathology: an update
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia. Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82-98% often associated with ApoE epsilon 2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parietal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20-40% with additional, often minor vascular lesions, 7-10% "pure" vascular dementia, and 3-5% "mixed" dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than "pure" AD patients. Vascular lesions in AD include cortical microinfarcts, subcortical lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAA appears in ≈10% to 30% of unselected brain autopsies and 80% to 100% when in the presence of accompanying Alzheimer disease.136”
In the citing paper
“which virtually all individuals with AD and about a third of aged cognitively normal individuals have) [68, 179]”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [68]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“of currently used neuropathological diagnostic criteria for AD (Mirra et al., 1991; Braak and Braak, 1991; Hyman, 1998).”
BackgroundMethodMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 2×
“…to many authors, MD should be diagnosed only if there are sufficient vascular and degenerative lesions to make each diagnosis independently (Tomlinson et al., 1970; Boller et al., 1989; Erkinjuntti, 1988; Jellinger et al., 1990; Mirra et al., 1991), while others suggest the diagnosis of AD…”
Background15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · cited 2×
“that came to autopsy, but most patients had mixed disease without clear thresholds of pathological features that predicted dementia (Esiri et al., 2001).”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · cited 2×
“, 1991), while in the ADDTC criteria (Chui et al., 1992), a second cerebrovascular disorder in addition to AD must be shown to”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 6×
“…vessels (Claudio, 1996; Farkas et al., 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are considered important factors for disturbances of cerebral metabolism, reduced cerebral blood flow and neural metabolic changes (Shi et al., 2000; Farkas and Luiten, 2001).”
BackgroundInfluentialHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 4×
“Hypertension and hypercholesterinemia, independent of the ApoE genotype have been shown to be risk factors for AD (Hofman et al., 1997; Skoog et al., 1999).”
BackgroundInfluentialClinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Cited by
Items 501–600 of 681
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition
Cipriano, L., Saracino, D., Oliva, M., Campana, V., Puoti, G., Conforti, R., Fulgione, L., Signoriello, E., Bonavita, S., & Coppola, C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215323 · Cited by 7
“Almost all the previous neuropathological studies focused on CAA prevalence in AD, reporting a mean prevalence of CAA in AD brains of 85–95% [43, 44] and a strong relationship between CAA severity and AD neuropathological staging.”
van Dijk, S. E., Lak, J., Drenth, N., Hafkemeijer, A., Rombouts, S. A. R. B., van der Grond, J., & van Rooden, S. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28362 · Cited by 7
Mechanisms underlying microbleeds
Werring, D. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974892.009 · Cited by 7
Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging
Rakheja, R., Chandarana, H., Ponzo, F., Seltzer, A., Beltrán, L., Geppert, C., & Friedman, K. P. (2014) · PET Clinics · doi:10.1016/j.cpet.2013.10.007 · Cited by 7
“Moreover, some literature suggests that the prevalence of mixed dementia is vastly underreported and discovered only at autopsy.(74) This theory has significant clinical implications, because misdiagnosis of a specific dementia pattern in a patient with mixed dementia may expose patients to unnecessary treatment cost…”
BackgroundTang, Y., Li, Y., Wang, S., Zhu, M., Sun, Y., & Zhao, J.-Z. (2013) · Neurosurgical Review · doi:10.1007/s10143-013-0474-x · Cited by 8
Du, A., Schuff, N. W., Chao, L. L., Kornak, J., Ezekiel, F., Jagust, W. J., Kramer, J. H., Reed, B., Miller, B. L., Norman, D. M., et al. (2006) · International Congress Series · doi:10.1016/j.ics.2006.04.008 · Cited by 7
“T2-weighted MRI of the brain often shows regions of strong signal intensity in the white matter (WM), called white matter hyperintensities (WMH) in cognitive normal (CN) elderly subjects and patients with AD and a variety of other disorders [2,10,15,21].”
BackgroundNishizaki, T. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1408-y · Cited by 7
Cerebral amyloid angiopathy: A clinicopathological study of three cases
Panicker, J., Nagaraja, D., & Chickabasaviah, Y. (2010) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.70879 · Cited by 10
“[19] At this center, an autopsy study of 52 cases revealed the incidence of CAA in the population above 60 years to be 30% (unpublished observations).”
Neupane, S., & Hortobágyi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411811 · Cited by 6
“Deposition of A β in vessel walls (cerebral amyloid angiopathy) impairs vascular integrity and triggers local inflammation [143,146].”
Haußmann, R., Homeyer, P., Sauer, C., Grey, A., Krukowski, P., Brandt, M., Donix, M., & Linn, J. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6015 · Cited by 7
“5 Current metaanalytic data analyzing the prevalence of CAA in AD demonstrate a histopathologically ‐ based prevalence of 48%, 34 but estimates of CAA prevalence vary widely.”
Backgroundda Silva, J. F., Polk, F. D., Martin, P. E., Thai, S. H., Savu, A., Gonzales, M., Kath, A., Gee, M. T., & Pires, P. W. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14438 · Cited by 11
Yin, X., Sun, J., Wang, X., Wu, W., Chen, Z., Zhang, D., Xu, Y., Chen, Y., Qiu, W., Qian, X., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70100 · Cited by 9
Watanabe, N., Noda, Y., Nemoto, T., Iimura, K., Shimizu, T., & Hotta, H. (2020) · The Journal of Physiological Sciences · doi:10.1186/s12576-020-00785-8 · Cited by 6
Amyloid Spells and High Blood Pressure: Imminent Danger
Caetano, A., Pinto, M. M., Calado, S., & Baptista, M. V. (2014) · Case Reports in Neurology · doi:10.1159/000369922 · Cited by 6
Cell‐to‐Cell Communication and Vascular Dementia
Dietrich, H. H. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00175.x · Cited by 6
“Some occurrences of AD are considered nonvascular disease because no vascular alterations such as the CAA or other vessel lesions could be detected [29].”
BackgroundBousser, M., & Chabriat, H. (2012) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31836-9 · Cited by 7
Clinical effects of restarting antiplatelet therapy in patients with intracerebral hemorrhage
Jung, N. Y., & Cho, J. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107361 · Cited by 7
“CAA commonly occurs in elderly patients and causes vessel wall weakening related to the neurodegenerative condition [29].”
BackgroundCorrection: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
Sandebring, A., Welander, H., Winblad, B. G., Graff, C., & Tjernberg, L. O. (2013) · PLoS ONE · doi:10.1371/annotation/9e7b419c-4f85-4922-89f6-b7e4d30149c4 · Cited by 6
Kays, M., Kelly, A. M., McGinnis, F., Woods, C., Herron, E., Brown, C. M., & Coulibaly, A. P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1672768 · Cited by 6
Zhang, X.-Y., Zhang, H., Bao, Q.-N., Yin, Z., Li, Y., Xia, M., Chen, Z., Zhong, W., Wu, K., Yao, J., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311016 · Cited by 5
Case Report: Ischemic brain infarction and cognitive dysfunction syndrome in an aged dog
Kang, M., Jeong, W.-P., Nam, C.-S., Yoon, J.-W., Choi, D.-M., Lee, G.-S., Kim, Y.-J., Dan, T.-J., & Park, H. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1563798 · Cited by 5
“These vascular lesions likely disrupted critical neural networks responsible for cognition and behavior by reducing regional cerebral perfusion and contributing to microvascular pathology, such as blood–brain barrier dysfunction and neuronal damage (9, 22).”
InfluentialNeuropathologic Changes in People With Essential Tremor With Dementia: A Postmortem Study
Wainman, E., Berry, D. S., Hernandez, N. C., Guy, T. O., Cosentino, S., Faust, P. L., & Louis, E. D. (2025) · Neurology · doi:10.1212/wnl.0000000000214310 · Cited by 8
The Frequency of Cerebral Amyloid Angiopathy in Primary Age-Related Tauopathy
Walker, J. M., Richardson, T. E., Farrell, K. W., White, C. L., & Crary, J. F. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab131 · Cited by 5
“While CAA may be clinically silent, it is a frequent underlying cause of intracerebral hemorrhage (ICH) and contributor to cognitive impairment in elderly populations (1), although there is significant variation in the incidence and prevalence of CAA between cohorts (2).”
BackgroundJeong, H., Pan, Y., Akhter, F., Volkow, N. D., Zhu, D., & Du, C. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241304893 · Cited by 5
“4–7 Indeed, there is increasing evidence of vascular defects in the brain of early-stage AD patients, 8–10 including cerebral hypoperfusion, 11 leakage of the blood-brain barrier, 12 and CAA that eventually leads to infarcts, microbleeds, and cerebral hemorrhages.”
Update on Amyloid-associated Intracerebral Haemorrhage
Grysiewicz, R. A., & Gorelick, P. B. (2012) · European Neurological Review · doi:10.17925/enr.2012.07.01.22 · Cited by 5
“Epidemiology Sporadic CAA is a common pathological finding in the elderly, which is detected in approximately 10–40 % of brains ≥65 years of age.(18) CAA is even more prevalent in elderly subjects with concomitant AD, and has been reported to be present in 80 % of these individuals.”
BackgroundInfluentialJoseph‐Mathurin, N., & Raji, C. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_23 · Cited by 5
Feng, T., Hu, X., Fukui, Y., Bian, Z., Bian, Y., Sun, H., Takemoto, M., Yunoki, T., Nakano, Y., Morihara, R., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215246 · Cited by 5
Shusta, E. V. (2005) · CRC Press eBooks · doi:10.3109/9780203025956-3 · Cited by 5
Hypertension and progressive supranuclear palsy: Is everything so clear?
Sibon, I., Macia, F., Vital, A., Delacourte, A., & Tison, F. (2004) · Movement Disorders · doi:10.1002/mds.20275 · Cited by 5
Angiopathie amyloïde cérébrale sporadique
Cabrejo, L., Chassagne, P., Doucet, J., Laquerrière, A., Puech, N., & Hannequin, D. (2006) · Revue Neurologique · doi:10.1016/s0035-3787(06)75118-9 · Cited by 5
14 Amyloid Imaging and (What is “Normal”?) Aging
Klunk, W. E., & Mathis, C. A. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0014 · Cited by 5
Elderly and forgetful with transient neurological spells: A story of two amyloids?
Charidimou, A. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.02.034 · Cited by 6
“CAA also seems to form an integral part in Alzheimer's disease (AD), being present in nearly all brains with AD-type pathology [4] and probably suggesting a close molecular relationship between vascular and parenchymal amyloid-β deposits.”
BackgroundAmyloid Hypothesis and Alzheimer's Disease
Sun, X., & Zhang, Y. (2011) · InTech eBooks · doi:10.5772/28947 · Cited by 4
Amyloid Imaging with AV45 (18F-florbetapir) in a Cognitively Normal AβPP Duplication Carrier
Saint‐Aubert, L., Planton, M., Hannequin, D., Albucher, J., Delisle, M., Payoux, P., Hitzel, A., Viallard, G., Péran, P., Campion, D., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111598 · Cited by 7
“It has been shown that typical CAA pathology is often found in AD [26].”
Comparing Cerebral White Matter Lesion Burdens between Parkinson’s Disease with and without Dementia
Choi, S., Evidente, V. G. H., & Caviness, J. N. (2010) · Journal of Movement Disorders · doi:10.14802/jmd.10002 · Cited by 5
Hasegawa, I., Hirayoshi, Y., Minatani, S., Mino, T., Takeda, A., & Itoh, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126422 · Cited by 4
“The Aβ peptide is known to be generated by sequential cleavage of the amyloid precursor protein in neurons in the cerebral cortex and may be transported to the penetrating arteries and leptomeningeal arteries [10].”
BackgroundProteopathic lesions in the brain of a super‐aged chimpanzee (Pan troglodytes)
Iwaide, S., Yanai, T., & Murakami, T. (2021) · Journal of Medical Primatology · doi:10.1111/jmp.12530 · Cited by 4
Aine, C. J., Adair, J. C., Knoefel, J. E., Sanfratello, L., & Stephen, J. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-33045-2_31 · Cited by 4
Cerebral microbleeds in relation to cerebral amyloidangiopathy
Khan, M. A., Viswanathan, A., & Greenberg, S. M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974892.015 · Cited by 5
Santano, C., de Lara, M. P., & Pintor, J. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-956-7_10 · Cited by 6
The Aging Brain: From Physiology to Neurodegeneration
Rajput, R., Kaur, R., Chadha, R., Mani, S., Rachana, R., Kaur, H., & Singh, M. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch001 · Cited by 4
Cerebral amyloid angiopathy related Inflammation presenting as steroid responsive brain mass
Şilek, H., & Erbaş, B. (2018) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.22592-18.2 · Cited by 3
Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's diseases
Bhandari, M., Tiwari, R. K., Chanda, S., & Bonde, G. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00003-5 · Cited by 5
Greenberg, S. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511691836.005 · Cited by 3
Angiopathie Amyloïde Cérébrale : avancées récentes et perspectives
Raposo, N., Pariente, J., Albucher, J., Olivot, J., Calvière, L., Viguier, A., Bonneville, F., Barbieux‐Guillot, M., & Chollet, F. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2020.12.005 · Cited by 8
Avances en la fisiopatología de la demencia vascular
Jellinger, K. A. (2004) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(04)74930-6 · Cited by 4
Self-citationAi-she, G., Du, H., Gao, Q., Wang, Y., Wang, X.-Y., Liu, J., & Lu, B. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515628051 · Cited by 3
“In the brain of patients with AD, both the presence of inflammatory mediators and the increased expression of the full complement cascade in the vicinity of Ab deposits strongly indicate the contribution of inflammation to AD pathogenesis.(7,8) Many adhesion molecules and chemokines are involved in the neuroinflammato…”
BackgroundAPP-Based Transgenic Models: The APP23 Model
Dam, D. V., & Deyn, P. P. D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_20 · Cited by 3
The origin and clinical importance of cerebral microbleeds
Imaizumi, T. (2013) · Nosotchu · doi:10.3995/jstroke.35.397 · Cited by 3
Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
Sandebring, A., Welander, H., Winblad, B. G., Graff, C., & Tjernberg, L. O. (2013) · PLoS ONE · doi:10.1371/annotation/b4d7aee1-6578-4e73-b15d-67aef9b3da8c · Cited by 3
Bradley, C., Orchard, V., Sykes, R., McKinley, G., McConnachie, A., Donnelly, P. S., Watt, J. K., Kellman, P., Quinn, T., Fullerton, N., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-088372 · Cited by 2
Saiz-Vázquez, O., Landa, S. U., & Puente-Martínez, A. (2025) · Kidney & Blood Pressure Research · doi:10.1159/000546395 · Cited by 4
“Cerebral microbleeds and white matter lesions caused by vascular damage in HS have been linked to AD-related neurodegeneration [90].”
Aortic Stiffness and Alzheimer’s Disease: The Medin Connection
Triposkiadis, F. K., Xanthopoulos, A. V., Boudoulas, H. K., & Brutsaert, D. L. (2025) · Biomolecules · doi:10.3390/biom15081148 · Cited by 2
Laslo, A., Boghițoiu, T., Chinezu, L., Manu, D. R., Ivănescu, A. D., Cordoș, B. A., Wilson, M. R., Bănescu, C. V., Fryer, J. D., Verma, A. K., et al. (2025) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70037 · Cited by 2
Park, J. H., Choi, J., Kim, G.-Y., Kim, M., Park, S., & Koh, Y. H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.11.021 · Cited by 4
Cerebral amyloid angiopathy and Alzheimer's and related pathologies across APOE genotypes
Mehta, R. I., Wang, T., Leurgans, S. E., Bennett, D. A. A., & Schneider, J. A. (2026) · Brain · doi:10.1093/brain/awag025 · Cited by 5
Reuck, J. D., Cordonnier, C., Deramecourt, V., Auger, F., Durieux, N., Leys, D., Pasquier, F., Maurage, C., & Bordet, R. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.08.012 · Cited by 3
A Case of Cerebral Amyloid Angiopathy Presented with Cognitive Decline and Hoarding Behavior
Lee, J., Lee, S. I., Kim, S. G., Lee, J. B., & Jung, H. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0328 · Cited by 2
Autoimmune hypothesis of Alzheimer’s disease: unanswered question
Arshavsky, Y. I. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00259.2024 · Cited by 2
Jensen‐Kondering, U., Margraf, N. G., Pikija, S., Rak‐Frattner, K., Malojčić, B., Frol, S., Oblak, J. P., de la Riva, P., Albájar, I., DiFrancesco, J. C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041908 · Cited by 2
Animal Models of Alzheimer’s Disease
Kiyota, T. (2013) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4614-8794-4_35 · Cited by 3
Lumempouw, S. F., Misbach, J., & Diatri, N. (2007) · Medical Journal of Indonesia · doi:10.13181/mji.v16i2.264 · Cited by 2
Microbleeds in relation to specific populations, diseases and neurological symptoms
Werring, D. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974892.012 · Cited by 2
Yang, C. H. (2003) · Yonago acta medica · Cited by 2
Inoue, Y., Nakajima, M., Inatomi, Y., Masuda, T., Misumi, Y., Nomura, T., Uetani, H., Hirai, T., & Ueda, M. (2022) · Internal Medicine · doi:10.2169/internalmedicine.8630-21 · Cited by 2
“Patients with CAA also rarely develop CAA-related inflammation (CAA-ri), which manifests as reversible encephalopathy and demonstrates a favorable response to immunosuppressive treatment (2).”
BackgroundOptical Coherence Tomography in Alzheimer’s Disease
Coppola, G., Parisi, V., Manni, G., Pierelli, F., & Sadun, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-24085-5_7 · Cited by 2
Sharafi, S. M., Sylvestre, J., Chevrefils, C., Soucy, J., & Lesage, F. (2019) · Clinical and Translational Neurophotonics · doi:10.1117/12.2508557 · Cited by 3
Mediation Analysis in Understanding Mechanism of Alzheimer’s Disease Risk
Sajeev, G. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 3
Pepper-Yowell, A. R. (2014) · ThinkTech (Texas Tech University) · Cited by 2
Multi-scale Assessment of Brain Blood Volume and Perfusion in the APP/PS1 Mouse Model of AmyloidosisPreprint
Munting, L. P., Derieppe, M., Voortman, L. M., Khmelinskii, A., Suidgeest, E., Hirschler, L., Barbier, E., de Senneville, B. D., & van der Weerd, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.01.498298 · Cited by 2
“Cerebrovascular amyloid-β is commonly referred to as cerebral amyloid angiopathy (CAA), which has been estimated to co-occur in around 78 % to 98 % of the AD cases [11].”
BackgroundDiagnosis and Treatment of Inflammatory Cerebral Amyloid Angiopathy
Bruce, S. S., & Parikh, N. S. (2023) · Current Treatment Options in Neurology · doi:10.1007/s11940-023-00755-6 · Cited by 1
“It is also highly comorbid with Alzheimer’s disease (AD), with autopsy studies showing that CAA is present in > 80% of patients with AD [4].”
BackgroundComorbidity of cerebral amyloid angiopathy and Alzheimer's disease. Clinical case analysis
Emelin, А. Y., Lobzin, V. Y., Efimtsev, A. Y., & Владиславович, В. С. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/20742711-2023-6-85-94 · Cited by 1
Major or Mild Vascular Neurocognitive Disorder
Espiritu, A. I., Balakrishnar, K., Moradizadeh, M., Marlatt, N. E., & Burhan, A. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-47802-4_21 · Cited by 1
Global trends and prospects of ocular biomarkers in Alzheimer’s disease: a bibliometric analysis
Shen, Y., Zhang, X., Xu, C., & Zhu, Z. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1528527 · Cited by 1
“Given that AD is known to be associated with vascular changes (Jellinger, 2002), optical coherence tomography angiography (OCTA) — an advanced form of OCT that generates detailed images of the retinal vascular network without the use of contrast agents — could serve as a valuable early biomarker.”
Fang, C.-W., Hsieh, C., Yang, H., Tsai, C.-F., & Sung, S. (2025) · Thrombosis Research · doi:10.1016/j.thromres.2025.109332 · Cited by 2
Tian, Q., Liu, M., Zhong, F., Liu, X., & Lü, Y. (2026) · BMC Neurology · doi:10.1186/s12883-025-04581-y · Cited by 1
“In CAA patients, Aβ is primarily deposited in leptomeningeal and cortical (parenchymal) vessels [30, 31].”
Peripheral biomarkers of neuroinflammation in Alzheimer’s disease and vascular dementia
Ouyang, X., Chia, R. S. L., Chai, Y. L., Chong, Sim, M. A., Jo, D., Arumugam, T. V., Sethi, G., Dawe, G. S., Chen, C. P., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118077 · Cited by 3
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Biffi, A., & Rosand, J. M. (2012) · Springer eBooks · doi:10.1007/978-0-85729-209-4_5 · Cited by 1
“Prevalence increases to almost 80% for autopsy samples from patients with concomitant Alzheimer’s disease (AD) [ 24 ] .”
BackgroundDiscriminative analysis of non-linear brain connectivity for leukoaraiosis with resting-state fMRI
Lai, Y., Xu, L., Yao, L., & Wu, X. (2015) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2081378 · Cited by 1
“Leukoaraiosis (LA) is a type of white matter lesion frequently revealed as hyperintensities seen on T2 magnetic resonance image (MRI) of aging individuals[1], and these hyperintensities or LA maybe result from different pathological processes and have been described in various conditions including normal aging, vascul…”
BackgroundPhysical activity benefits for Alzheimer's disease patients (A Review)
Pano, G. (2014) · Journal of Human Sport and Exercise · doi:10.14198/jhse.2014.9.proc1.15 · Cited by 1
“…effect on frontal brain regions that are most vulnerable to aging, and for glucose intolerant adults with an increased risk of cognitive decline and AD, to deleterious consequences of diabetes- and AD-related vascular dysfunction (Manschot et al., 2006; Jellinger, 2002; Stopa et al., 2008).”
BackgroundAmyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation
Svedberg, M. M., Hellström‐Lindahl, E., Rahman, O., & Hall, H. (2012) · InTech eBooks · doi:10.5772/31813 · Cited by 1
“CAA is present in 80% or more of AD patients (Jellinger, 2002) and may therefore contribute significantly to the in vivo [11C]PIB signal and in vitro binding of PIB (Bacskai et al.”
BackgroundAMYLOID CLEARING IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE AND THE RISK OF CEREBRAL AMYLOID ANGIOPATHY.
Kile, S. J., & Olichney, J. (2007) · PubMed · Cited by 2
Alzheimer?s Disease: A Failure of Clearance of Soluble Metabolites from the Ageing Brain
Hawkes, R. O. C. C. (2011) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s5-e001 · Cited by 1
“Most commonly, CAA affects the leptomeningeal arteries present on the surface of the cerebral hemispheres, followed by arteries in the cerebral cortex, but is rarely observed in the striatum [6,7].”
BackgroundInfluentialMajor or Mild Vascular Neurocognitive Disorder
Burhan, A. M., Moradizadeh, M., & Marlatt, N. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-67555-8_21 · Cited by 1
Weidenfeller, C., & Shusta, E. V. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511546198.124 · Cited by 2
Kluckert, C., & Hüll, M. (2021) · PSYCH up2date · doi:10.1055/a-1220-4197 · Cited by 2
Smart Development of Nano Materials and Nanomedicine Formulations
Parashar, R., Prasad, S., Hemnani, N., & Suresh, P. K. (2024) · Smart nanomaterials technology · doi:10.1007/978-981-97-0308-1_4 · Cited by 2
Watson, B. E., Waugh, M. L., Foreman, N. J., & Moss, M. A. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2553927 · Cited by 3
“33 Previous studies on vascular cell lines treated with higher than physiological Aβ oligomer concentrations revealed that low micromolar concentrations of Aβ oligomers trigger apoptotic pathways in endothelial cells through upregulation of nuclear factor-kappa B (NF-KB), TNF-α, interlukin-6,…”
Micro-vascular Diseases of White Matter
Kim, W., & Yang, D. W. (2012) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2012.11.3.79 · Cited by 1
“연구에 따라 다르지만 AD 환자의 뇌조직에서 혈 관손상은 25-80%에서 관찰할 수 있다[16].”
The heterogeneity of vascular cognitive impairments and the issues of therapy
Катунина, Е. А. (2015) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2015-3-62-69 · Cited by 2
Optical Coherence Tomography in Alzheimer’s Disease
Coppola, G., Parisi, V., Manni, G., Pierelli, F., & Sadun, A. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-26269-3_13 · Cited by 2
Aine, C. J., Adair, J. C., Knoefel, J. E., Sanfratello, L., & Stephen, J. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-00087-5_31 · Cited by 1
Aine, C. J., Adair, J. C., Knoefel, J. E., Sanfratello, L., & Stephen, J. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-62657-4_31-1 · Cited by 1
Cardiovascular factors in dementia
Bidzan, L. (2022) · Psychiatria Polska · doi:10.12740/pp/150052 · Cited by 2
“A more appropriate direction seems to be to analyze as many factors as possible together [62].”
Magnetic Resonance Imaging in Pharmaceutical Safety Assessment
Hockings, P. D., & Beckmann, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-73317-9_19-1 · Cited by 1
The Contribution of Bone Marrow-Derived Cells to Cerebrovascular Formation and Integrity
Kobiler, D., & Glod, J. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-021-8_17 · Cited by 1
WORK GROUP ON ALZHEIMER'S DISEASE AND OTHER DEMENTIAS
Rabins, P. V., Rovner, B. W., Rummans, T. A., Schneider, L. S., Tariot, P. N., & Blass, D. M. (2010) · Cited by 1
What caused this intracerebral hemorrhage?
Radmanesh, F., & Rosand, J. M. (2019) · Wiley eBooks · doi:10.1002/9781118492390.ch8 · Cited by 1
Predictors of Hiv-related Neurocognitive Impairment in an Hiv/aids Population
Steinberg, T. C. (2012) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc149667 · Cited by 2
“Hypertension causes an increase in neurofibrilliary tangles and amyloid plaques commonly seen in individuals with Alzheimer’s disease and vascular dementia (Jellinger, 2002).”
Background
Metadata
- Authors
- Jellinger, K. A.
- Affiliations
- Ludwig Boltzmann für Klinische Neurobiologie (AT)
- Corresponding author
- Jellinger, K. A.
- ORCID
- Jellinger, K. A.
- Venue
- Journal of Neural Transmission
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 5-6
- Pages
- 813-836
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2084675121
- Cited by
- 680
- References
- 114
- Citations by year
- 2026: 7 · 2025: 25 · 2024: 32 · 2023: 19 · 2022: 38 · 2021: 32 · 2020: 22 · 2019: 26 · 2018: 23 · 2017: 22 · 2016: 30 · 2015: 44 · 2014: 38 · 2013: 27 · 2012: 39
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebrovascular pathology, cerebral amyloid angiopathy, cerebral hemorrhage, microinfarcts, lacunes, white matter lesions, mixed dementia, vascular dementia, cognitive decline, dementia progression, blood-brain barrier dysfunction
- MeSH terms
- Alzheimer Disease, Blood Vessels, Cerebrovascular Circulation, Cerebrovascular Disorders, Diagnosis, Differential, Humans, Microcirculation, Risk Factors, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.